Compare SPHL & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPHL | PAVM |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0M | 9.3M |
| IPO Year | 2024 | 2016 |
| Metric | SPHL | PAVM |
|---|---|---|
| Price | $4.51 | $0.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 65.3K | ★ 484.1K |
| Earning Date | 12-29-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,956,226.00 | $29,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $450.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.76 | $0.30 |
| 52 Week High | $62.40 | $1.06 |
| Indicator | SPHL | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 79.86 | 45.64 |
| Support Level | $2.77 | $0.31 |
| Resistance Level | $4.20 | $0.35 |
| Average True Range (ATR) | 0.41 | 0.03 |
| MACD | 0.46 | 0.00 |
| Stochastic Oscillator | 90.39 | 35.23 |
Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.